The Clinical Study on Symptomatic Adenomyosis Treated by Transcatheter Uterine Artery Embolization

In: Journal of Guangxi Traditional Chinese Medical University · 2004 · W2381838690
article OA: closed CC0
View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-07-16

Transcatheter uterine artery embolization with Lipiodol, pingyangmycin emulsion, and Gelfoam strip effectively treated symptomatic adenomyosis, resolving dysmenorrhea and menorrhagia, shrinking uterine volume, and increasing hemoglobin levels without serious complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

[Objective]To investigate the efficiency of transcatheter uterine artery embolization (TUAE) for the treatment of symptomatic adenomyosis.[Materials and Methods]Bilateral uterine aterial embolization with Lipiodol, pingyangmycin emulsion and Gelfoam strip was carried out in all patients. Lipiodol of 8~10ml (mean 9 ml) ,pingyang mycin of 8mg and Gelfoam strip 1.0~1.5 flaps were used.[Results]The mean duration of follow-up was 20.2 months. Improvement of dysmenorrhoea was obtained at the rate of 100.0% (completely disappeared at 85.7%), and improvement of menorrhagia at 100%. The hemoglobin concentration was significantly increased or restored to normal in 6 months after the surgery. Ultrasonic reexamination 6 months after TUAE showed that the uterine volume was decreased by a mean of 46.6%.No serious complications occurred in all cases.[Conclusion]TUAE shows good effect in the treatment of symptomatic adenomyosis although large sample is needed for further observations.

My notes (saved in your browser only)

Condition tags

adenomyosisdysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK